the first reporting period expires at the end of the third calendar month following the first supply of carvedilol.
111 the patentees also point to the possibility that genrx could, at any stage, make an application to reduce the price of its carvedilol products.
it reports that the study medication was initiated at a dose of 6.25 mg bi-daily and increased over one month to 25 mg per patient below 75 kg or 50 mg for a patient over 75 kg, twice daily.